Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Pd-Catalyzed Asymmetric Allylic Cycloaddition of N-Containing Allylic Carbonates with Isocyanates.

Khan I, Shah BH, Zhao C, Xu F, Zhang YJ.

Org Lett. 2019 Dec 6;21(23):9452-9456. doi: 10.1021/acs.orglett.9b03662. Epub 2019 Nov 8.

PMID:
31702930
2.

Enantioselective Synthesis of Isoxazoline N-Oxides via Pd-Catalyzed Asymmetric Allylic Cycloaddition of Nitro-Containing Allylic Carbonates.

Zhao C, Shah BH, Khan I, Kan Y, Zhang YJ.

Org Lett. 2019 Nov 15;21(22):9045-9049. doi: 10.1021/acs.orglett.9b03443. Epub 2019 Nov 7.

PMID:
31697086
3.

Pd-Catalyzed regio- and enantioselective allylic substitution with 2-pyridones.

Khan S, Shah BH, Khan I, Li M, Zhang YJ.

Chem Commun (Camb). 2019 Oct 29;55(87):13168-13171. doi: 10.1039/c9cc07482a.

PMID:
31620731
4.

Health system preparedness in Pakistan for crisis management: a cross-sectional evaluation study.

Ul-Haq Z, Shah BH, Ardakani M, Khan SA, Muhammad S, Farooq S, Khan SH, Huda Q.

East Mediterr Health J. 2019 Oct 7;25(8):553-561. doi: 10.26719/emhj.18.072.

5.

Management of Acquired Compressive Myelopathy due to Spinal Fluorosis.

Modi JV, Tankshali KV, Patel ZM, Shah BH, Gol AK.

Indian J Orthop. 2019 Mar-Apr;53(2):324-332. doi: 10.4103/ortho.IJOrtho_570_17.

6.

Prevalence and Association of Obesity with Self-Reported Comorbidity: A Cross-Sectional Study of 1321 Adult Participants in Lasbela, Balochistan.

Khan I, Ul-Haq Z, Taj AS, Iqbal AZ, Basharat S, Shah BH.

Biomed Res Int. 2017;2017:1076923. doi: 10.1155/2017/1076923. Epub 2017 Oct 12.

7.

Pulmonary Silicosis Presents with Pleural Effusion.

Salih M, Aljarod T, Ayan M, Jeffrey M, Shah BH.

Case Rep Med. 2015;2015:543070. doi: 10.1155/2015/543070. Epub 2015 Sep 7.

8.

Short-term retention of labeled chondrocyte subpopulations in stratified tissue-engineered cartilaginous constructs implanted in vivo in mini-pigs.

Chawla K, Klein TJ, Schumacher BL, Jadin KD, Shah BH, Nakagawa K, Wong VW, Chen AC, Masuda K, Sah RL.

Tissue Eng. 2007 Jul;13(7):1525-37.

PMID:
17532744
9.

Mechanisms of endothelin-1-induced MAP kinase activation in adrenal glomerulosa cells.

Shah BH, Baukal AJ, Chen HD, Shah AB, Catt KJ.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):79-88.

10.

Protein phosphatase 5 as a negative key regulator of Raf-1 activation.

Shah BH, Catt KJ.

Trends Endocrinol Metab. 2006 Dec;17(10):382-4. Epub 2006 Nov 3. Review.

PMID:
17084641
11.

Dependence of GnRH-induced phosphorylation of CREB and BAD on EGF receptor transactivation in GT1-7 neuronal cells.

Neithardt A, Farshori MP, Shah FB, Catt KJ, Shah BH.

J Cell Physiol. 2006 Sep;208(3):586-93.

PMID:
16741954
12.

TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease.

Shah BH, Catt KJ.

Trends Pharmacol Sci. 2006 May;27(5):235-7. Epub 2006 Apr 5. Review.

PMID:
16600387
13.
14.

Roles of LPA3 and COX-2 in implantation.

Shah BH, Catt KJ.

Trends Endocrinol Metab. 2005 Nov;16(9):397-9. Epub 2005 Oct 12.

PMID:
16226033
15.

Estrogen stimulation of COX-2-derived PGI2 confers atheroprotection.

Shah BH.

Trends Endocrinol Metab. 2005 Jul;16(5):199-201. Review.

PMID:
15950485
16.

Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor.

Shah BH, Baukal AJ, Shah FB, Catt KJ.

Mol Endocrinol. 2005 Oct;19(10):2535-48. Epub 2005 May 31.

PMID:
15928312
17.

Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.

Shah BH, Neithardt A, Chu DB, Shah FB, Catt KJ.

J Cell Physiol. 2006 Jan;206(1):47-57.

PMID:
15920762
18.

Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.

Olivares-Reyes JA, Shah BH, Hernández-Aranda J, García-Caballero A, Farshori MP, García-Sáinz JA, Catt KJ.

Mol Pharmacol. 2005 Aug;68(2):356-64. Epub 2005 May 19.

PMID:
15905421
20.

Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy.

Shah BH, Catt KJ.

Trends Endocrinol Metab. 2004 Aug;15(6):241-3. Review.

PMID:
15358274
21.

Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.

Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, Catt KJ.

Mol Endocrinol. 2004 Aug;18(8):2035-48. Epub 2004 May 13.

PMID:
15143154
22.

Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor.

Hunyady L, Gáborik Z, Shah BH, Jagadeesh G, Clark AJ, Catt KJ.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):89-100.

PMID:
15134806
23.

Matrix metalloproteinases in reproductive endocrinology.

Shah BH, Catt KJ.

Trends Endocrinol Metab. 2004 Mar;15(2):47-9. Review.

PMID:
15080147
24.

GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences.

Shah BH, Catt KJ.

Trends Neurosci. 2004 Jan;27(1):48-53. Review. No abstract available.

PMID:
14698610
26.

The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes.

Hasan Z, Shah BH, Mahmood A, Young DB, Hussain R.

Tuberculosis (Edinb). 2003;83(5):299-309.

PMID:
12972343
27.

Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells.

Farshori PQ, Shah BH, Arora KK, Martinez-Fuentes A, Catt KJ.

J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):337-47.

PMID:
12943720
28.

A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy.

Shah BH, Catt KJ.

Trends Pharmacol Sci. 2003 May;24(5):239-44. Review.

PMID:
12767723
29.
30.
31.

Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes.

Shah BH, Alberto Olivares-Reyes J, Yesilkaya A, Catt KJ.

Mol Endocrinol. 2002 Mar;16(3):610-20.

PMID:
11875120
33.

Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.

Shah BH, Rasheed H, Rahman IH, Shariff AH, Khan FL, Rahman HB, Hanif S, Saeed SA.

Exp Mol Med. 2001 Dec 31;33(4):226-33.

PMID:
11795484
34.

An investigation of cyclooxygenase and signalling inhibitors on 5-hydroxytryptamine- and epinephrine-induced platelet activation.

Saeed SA, Rasheed H, Gilani AH, Hashmi A, Shah BH.

Proc West Pharmacol Soc. 2001;44:159-62. No abstract available.

PMID:
11793969
35.

Epidermal growth factor receptor transactivation in angiotensin II-induced signaling: role of cholesterol-rich microdomains.

Shah BH.

Trends Endocrinol Metab. 2002 Jan-Feb;13(1):1-2. No abstract available.

PMID:
11750852
36.

Agonist-induced signaling, desensitization, and internalization of a phosphorylation-deficient AT1A angiotensin receptor.

Olivares-Reyes JA, Smith RD, Hunyady L, Shah BH, Catt KJ.

J Biol Chem. 2001 Oct 12;276(41):37761-8. Epub 2001 Aug 8.

37.

Wortmannin inhibits platelet aggregation produced by interaction of gamma-aminobutyric acid and the calcium tonophore, A23187.

Saeed SA, Connor JD, Rasheed H, Gilani AH, Lodhi S, Ali SS, Rashid S, Khan E, Shah BH.

Res Commun Mol Pathol Pharmacol. 2001 Jul;109(1-2):87-93.

PMID:
11458988
38.
39.

Studies on antihypertensive and antispasmodic activities of methanol extract of Acacia nilotica pods.

Gilani AH, Shaheen F, Zaman M, Janbaz KH, Shah BH, Akhtar MS.

Phytother Res. 1999 Dec;13(8):665-9.

PMID:
10594935
40.

Atherosclerosis and plaque rupture: an update.

Afzal MN, Saeed SA, Shah BH.

J Pak Med Assoc. 1999 Feb;49(2):37-43. Review. No abstract available.

41.
42.
43.

Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathways.

Shah BH, Siddiqui A, Qureshi KA, Khan M, Rafi S, Ujan VA, Yakoob MY, Rasheed H, Saeed SA.

Exp Mol Med. 1999 Mar 31;31(1):42-6. Erratum in: Exp Mol Med. 2009 Sep;41(9):686. Yaqub, Y [corrected to Yakoob, M Y].

PMID:
10231022
44.

Myocardial ischaemia and infarction in isoprenaline-treated rabbits: role of cyclooxygenases.

Saeed SA, Gilani AH, Sultan BH, Karim RM, Shah BH.

Biochem Soc Trans. 1998 Nov;26(4):S342. No abstract available.

PMID:
10047856
45.

Insulin-mediated stimulation of ChAT and c-Jun in the developing retina neurons involves PI 3-kinase.

Hausman RE, Ren Y, Ruiz JF, Shah BH.

Biochem Soc Trans. 1998 Nov;26(4):S312. No abstract available.

PMID:
10047826
46.

Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.

Saeed SA, Afzal MN, Shah BH.

Life Sci. 1998;63(20):1835-41.

PMID:
9820127
47.

The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx.

Shah BH, Nawaz Z, Virani SS, Ali IQ, Saeed SA, Gilani AH.

Biochem Pharmacol. 1998 Oct 15;56(8):955-60.

PMID:
9776305
48.

Esculetin prevents liver damage induced by paracetamol and CCL4.

Gilani AH, Janbaz KH, Shah BH.

Pharmacol Res. 1998 Jan;37(1):31-5.

PMID:
9503477
49.

Quercetin exhibits hepatoprotective activity in rats.

Gilani AH, Janbaz KH, Shah BH.

Biochem Soc Trans. 1997 Nov;25(4):S619. No abstract available.

PMID:
9450047
50.

The inhibition of prostaglandin biosynthesis by human haptoglobin and its relationship with haemoglobin binding.

Saeed SA, Mahmood F, Shah BH, Gilani AH.

Biochem Soc Trans. 1997 Nov;25(4):S618. No abstract available.

PMID:
9450046

Supplemental Content

Support Center